期刊文献+

甲胎蛋白阳性胃癌的临床病理特征与预后分析 被引量:6

Clinicopathology and prognosis of alpha fetoprotein-producing gastric carcinoma
原文传递
导出
摘要 目的分析甲胎蛋白阳性胃癌(AFPGC)的临床病理特征及预后。方法回顾性分析1998年1月至2018年12月期间在贵州省人民医院初诊为胃癌的2671例患者,按照纳入和排除标准筛选AFPGC组,得到相同病例数的AFP阴性胃癌组。结果共有98例AFPGC,占同期胃癌的4.5%,以老年男性患者为主,男女比例为2.16∶1,平均年龄为(65±12)岁。与术前相比,多数患者术后血清AFP水平显著下降(中位值:52 ng/ml比5 ng/ml,Z=-2.736,P=0.001)。与AFP阴性胃癌组相比,AFPGC组患者治疗前血清AFP和CEA水平更高(均P<0.05),更易发生脉管浸润(62.71%比40.68%)和肝转移(31.63%比6.12%),均P<0.05。两组患者在肿瘤大小、肿瘤部位、组织分化程度、淋巴结转移等方面差异均无统计学意义(均P>0.05)。AFPGC组患者的预后差于AFP阴性胃癌组患者(P<0.05),单因素生存分析结果显示:AFPGC患者预后与患者术前血清AFP水平、TNM分期、淋巴结转移、同时性肝转移及脉管浸润均有关(均P<0.05);COX多因素生存分析发现术前血清AFP水平是影响患者预后的独立危险因素(P<0.05)。结论AFPGC是一种特殊类型的胃癌,发病率低,易发生脉管浸润和肝转移,预后更差,血清AFP水平是影响AFPGC患者预后的独立危险因素。 Objective To analyze the clinicopathological features and prognostic factors of alpha‐fetoprotein‐producing gastric carcinoma(AFPGC).Methods A retrospective analysis was made on 2671 GC patients admitted from Jan 1998 to Dec 2018,AFPGC patients and matching AFP negative GC cases were enrolled and their clinicopathological features and prognostic factors were analyzed.The survival curve was drawn by Kaplan-Meier method.Log-rank test was used to test the significance,Univariate analysis was performed by using COX proportional hazard model.Results There were 98 AFPGC in this study accounting for 4.5%of all GC of the corresponding time period.The proportion of male to female was 2.16∶1,the average age was(65±12)years.The serum AFP levels significantly decreased after operation in most patients(median:52 ng/ml vs.5 ng/ml,Z=-2.736,P=0.001).Serum AFP and CEA levels in patients with AFPGC before treatment were significantly higher than that in patients with AFP negative GC(both P<0.05).Vascular invasion(62.71%vs.40.68%)and liver metastasis(31.63%vs.6.12%)were more likely to occur in AFPGC groups(both P<0.05).However,there was no significant difference between the two groups in tumor size,location,differentiation and lymph node metastasis(all P>0.05).The prognosis of AFPGC was significant pooer than that in AFP negative GC(P<0.05).Prognosis of AFPGC patients was significantly correlated with preoperative serum AFP level,TNM stage,lymph node metastasis,simultaneous liver metastasis and vascular invasion(all P<0.05).COX multivariate survival analysis found that preoperative serum AFP level was independent risk factors of patients with AFPGC(P<0.05).Conclusion AFPGC is a special GC charactering poor prognosis.
作者 徐开盛 李永柏 黄进堂 王少勇 张忠民 颜艺超 Xu Kaisheng;Li Yongbai;Huang Jintang;Wang Shaoyong;Zhang Zhongmin;Yan Yichao(Department of General Surgery,Guizhou Provincial People's Hospital,Guiyang 550002,China;Department of Gastroenterological Surgery,Peking University International Hospital,Beijing 102206,China)
出处 《中华普通外科杂志》 CSCD 北大核心 2021年第8期585-590,共6页 Chinese Journal of General Surgery
基金 国家自然科学基金青年科学基金项目(81702336) 北京大学国际医院院内科研基金(YN2019XQ01)。
关键词 胃肿瘤 甲胎蛋白类 病理学 临床 预后 Stomach neoplasms Alpha-fetoproteins Pathology,clinical Prognosis
  • 相关文献

参考文献4

二级参考文献28

  • 1杨春康,赵文锦,戴起宝,张惠灏,郑炜.胃肝样腺癌临床特点及诊治分析[J].中华胃肠外科杂志,2007,10(3):245-248. 被引量:9
  • 2Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J].The Lancet.2010(9742) 被引量:1
  • 3Jong-Han Kim,You-Jin Jang,Sung-Soo Park,Seong-Heum Park,Young-Jae Mok.Benefit of Post-operative Surveillance for Recurrence after Curative Resection for Gastric Cancer[J].Journal of Gastrointestinal Surgery.2010(6) 被引量:1
  • 4Narikazu Boku,Seiichiro Yamamoto,Haruhiko Fukuda,Kuniaki Shirao,Toshihiko Doi,Akira Sawaki,Wasaburo Koizumi,Hiroshi Saito,Kensei Yamaguchi,Hiroya Takiuchi,Junichiro Nasu,Atsushi Ohtsu.Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study[J].Lancet Oncology.2009(11) 被引量:1
  • 5Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J].Lancet Oncology.2008(3) 被引量:1
  • 6Naohiko Koide,Akihito Nishio,Jun Igarashi,Shoji Kajikawa,Wataru Adachi,Jun Amano.α-Fetoprotein–producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis[J].The American Journal of Gastroenterology.1999(6) 被引量:1
  • 7Takashi Aiko,Mitsuru Sasako.The new Japanese Classification of Gastric Carcinoma: Points to be revised[J].Gastric Cancer.1998(1) 被引量:1
  • 8Shohei Koyama M.D.,Tsugio Ebihara M.D.,Toshiaki Osuga M.D.Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma[J].Gastroenterologia Japonica.1987(4) 被引量:1
  • 9C. G. Bergstrand,Birgit Czar.Demonstration of a New Protein Fraction in Serum from the Human Fetus[J].Scandinavian Journal of Clinical & Laboratory Investigation.1956(2) 被引量:1
  • 10Liu X, Cheng Y, Sheng W, et al. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases[J]. J Surg Oncol, 2010,102(3) :249-255. 被引量:1

共引文献94

同被引文献61

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部